Keywords: uk, pharma, return, ceo, remuneration, mixed, celltech

UK pharma: return on CEO remuneration mixed

Article | 16 July 2001

Celltech chief executive Peter Fellner received a total remuneration ofL6.7 million ($9.4 million), albeit only L358,000 in actual salary and, under ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amersham

Astra Zeneca

AstraZeneca

GlaxoSmithKline

GSK

Go to company listing